Log in | Register

An overview on severe infections in Europe

George Dimopoulos| Murat Akova
What's New in Intensive Care
Volume 43, Issue 5 / May , 2017

Pages 686 - 689

No abstract available.

References

  1. Doganay M, Demiraslan H (2016) Refugees of the Syrian civil war: impact on reemerging infection, health services, and biosecurity in Turkey. Health Sec 14:220–225
    • View reference on publisher's website
  2. ECDC (2016) Rapid risk assessment. Crimean Congo haemorrhagic fever in Spain. http://ecdc.europa.eu/en/publications/Publications/crimean-congo-haemorrhagic-fever-spain-risk-assessment.pdf. Accessed 6 Oct 2016
  3. ECDC (2016) Communicable disease threats report. Week 41. http://ecdc.europa.eu/en/publications/Publications/communicable-disease-threats-report-15-oct-2016.pdf. Accessed 6 Oct 2016
  4. Crum-Cianflone NF (2016) Invasive aspergillosis associated with severe influenza infections. Open Forum Infect Dis 3(3):171
    • View reference on publisher's website
  5. Montagna MT, Lovero G, Borghi E et al (2014) Candidemia in intensive care unit: a nationwide prospective observational survey (GISIA-3 study) and review of European literature from 2000 through 2013. Eur Rev Med Pharma Sci 18:661–674
  6. Akova M (2016) Epidemiology of antimicrobial resistance in bloodstream infections. Virulence 7:252–266
    • View reference on publisher's website
    • View reference on PubMed
  7. Lee CR, Lee JH, Park KS, Kim YB, Jeong BC, Lee SH (2016) Global dissemination of carbapenemase-producing Klebsiella pneumoniae: epidemiology, genetic context, treatment options, and detection methods. Front Microbiol 7:895
    • View reference on PubMed
  8. Marston HD, Dixon DM, Knisley JM, Palmore TN, Fauci AS (2016) Antimicrobial resistance. JAMA 316:1193–1204
    • View reference on publisher's website
    • View reference on PubMed
  9. Endimiani A, Jacobs MR (2016) The changing role of the clinical microbiology laboratory in defining resistance in Gram-negatives. Infect Dis Clin N Am 30:323–345
    • View reference on publisher's website
  10. Vincent JL, Bassetti M, François B, Karam G, Chastre J, Torres A, Roberts J, Taccone FS, Rello J, Calandra T, De Backer D, Welte T, Antonelli M (2016) Advances in antibiotic therapy in the critically ill. Crit Care 20:133–146
    • View reference on publisher's website
    • View reference on PubMed
  11. Cassir N, Rolain JM, Brouqui P (2014) A new strategy to fight antimicrobial resistance: the revival of old antibiotics. Front Microbiol 20(5):551
  12. Nicolau DP, Dimopoulos G, Welte T, Luyt CE (2016) Can we improve clinical outcomes in patients with pneumonia treated with antibiotics in the intensive care unit? Expert Rev Respir Med 10(8):907–918
    • View reference on publisher's website
    • View reference on PubMed
  13. Dugernier J, Wittebole X, Roeseler J, Michotte JB, Sottiaux T, Dugernier T, Laterre PF, Reychler G (2015) Influence of inspiratory flow pattern and nebulizer position on aerosol delivery with a vibrating-mesh nebulizer during invasive mechanical ventilation: an in vitro analysis. J Aerosol Med Pulm Drug Deliv 28(3):229–236
    • View reference on publisher's website
    • View reference on PubMed
  14. Kollef MH, Ricard JD, Roux D, Francois B, Ischaki E, Rozgonyi Z, Boulain T, Ivanyi Z, János G, Garot D, Koura F, Zakynthinos E, Dimopoulos G, Torres A, Danker W, Montgomery AB (2016) A randomized trial of the amikacin fosfomycin inhalation system for the adjunctive therapy of Gram-negative ventilator-associated pneumonia: IASIS Trial. Chest 16:62463–62467. doi:10.1016/j.chest.2016.11.026
  15. Abdul-Aziz MH, Lipman J, Akova M, Bassetti M, De Waele JJ, Dimopoulos G et al (2016) DALI Study Group. Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved PK/PD and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort. J Antimicrob Chemother 71(1):196–207
    • View reference on publisher's website
    • View reference on PubMed
  16. Roberts JA, Paul SK, Akova M, Bassetti M, De Waele JJ, Dimopoulos G, Kaukonen KM, Koulenti D, Martin C, Montravers P, Rello J, Rhodes A, Starr T, Wallis SC, Lipman J, DALI Study (2014) DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients? Clin Infect Dis 58(8):1072–1083
    • View reference on publisher's website
    • View reference on PubMed

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement